• Content Hubs
    • Bupa
    • UnitedHealthcare Global
  • Supplements
  • About
  • Alerts
  • Advertise
  • Events
  • Research
  • Contact
SUBSCRIBE
No Result
View All Result
Health & Protection
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy
Health & Protection
No Result
View All Result

Iress in sale talks after rejecting $2.63bn bid

by Graham Simons
29 July 2021
Share on FacebookShare on Twitter

Iress is in talks over a potential sale to EQT Fund Management after its board knocked back two initial bids to purchase the Australia-based financial software firm.

In the UK the firm is one of the main providers of sourcing software for protection insurance products and also operates systems for the mortgage advice process.

Iress confirmed it had received a “confidential, unsolicited, non-binding and indicative” proposal from EQT Fund Management to buy all Iress shares for between A$15.30 and A$15.50 per share – valuing the the business at around A$2.63bn (approximately £1.4bn).

It’s shares jumped 13% on the day after the news was revealed, to close trading on the Australian Stock Exchange at A$14.25 each, valuing the business at A$2.42bn.

This was up from A$12.51 at the close yesterday, with the fresh bid placing a 23% premium above yesterday’s value.

The firm’s board rejected the offer but said it had given EQT limited non-public information so “it can develop a proposal that is capable of being recommended to shareholders”.

It said that after careful consideration which included consultation with its financial and legal advisers, it “concluded this latest proposal also does not represent compelling value for shareholders”.

The board had already rejected a previous bid placed on 18 June 2021 for A$14.80 per share.

 

‘Greater opportunity than anticipated’

Iress was also far more bullish on its future, announcing the launch of a A$100m share buy-back programme and saying it believed it had previously undersold the opportunities available to it.

In a statement, Iress chief executive Andrew Walsh said it was clear “that the opportunity for Iress is greater than previously anticipated and current consensus”.

“We have built solid foundations enabling us to capture more market share in large addressable markets. We are executing our growth strategies including in the United Kingdom, in superannuation and for investment infrastructure.

“In completing the transition to a single technology platform we will also achieve greater operational leverage and speed to market.”

 

Next Post

Big firms get richer as insurance intermediary revenues rise

Mid-size advisers see PII premiums slashed as largest firms pay up

Mid-size advisers see PII premiums slashed as largest firms pay up

Initial research indicates advisers are resuming face-to-face client meetings

Initial research indicates advisers are resuming face-to-face client meetings

HAVE YOU READ?

The UK Health & Protection Awards 2025 supplement – the winners

The UK Health & Protection Awards 2025 supplement – the winners

1 December 2025

Read more

Vote for the PMI and protection providers giving you the best service

28 November 2025

Read more
Health & Protection

© 2025 Definite Article Limited. Design by 71 Media Limited.

  • About
  • Advertise
  • Privacy policy
  • Terms & Conditions
  • Contact

Follow Healthcare & Protection

X
No Result
View All Result
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy

No Result
View All Result
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy